Haemonetics Corp (HAE)
81.28
-2.18
(-2.61%)
USD |
NYSE |
Apr 19, 16:00
81.28
0.00 (0.00%)
After-Hours: 20:00
Haemonetics Enterprise Value: 4.915B for April 18, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 18, 2024 | 4.915B |
| April 17, 2024 | 4.987B |
| April 16, 2024 | 4.951B |
| April 15, 2024 | 4.987B |
| April 12, 2024 | 5.005B |
| April 11, 2024 | 5.071B |
| April 10, 2024 | 5.052B |
| April 09, 2024 | 5.098B |
| April 08, 2024 | 5.010B |
| April 05, 2024 | 4.976B |
| April 04, 2024 | 4.988B |
| April 03, 2024 | 4.939B |
| April 02, 2024 | 4.951B |
| April 01, 2024 | 4.983B |
| March 28, 2024 | 5.011B |
| March 27, 2024 | 4.947B |
| March 26, 2024 | 4.823B |
| March 25, 2024 | 4.832B |
| March 22, 2024 | 4.754B |
| March 21, 2024 | 4.754B |
| March 20, 2024 | 4.730B |
| March 19, 2024 | 4.613B |
| March 18, 2024 | 4.526B |
| March 15, 2024 | 4.476B |
| March 14, 2024 | 4.516B |
| Date | Value |
|---|---|
| March 13, 2024 | 4.554B |
| March 12, 2024 | 4.581B |
| March 11, 2024 | 4.656B |
| March 08, 2024 | 4.720B |
| March 07, 2024 | 4.625B |
| March 06, 2024 | 4.610B |
| March 05, 2024 | 4.562B |
| March 04, 2024 | 4.474B |
| March 01, 2024 | 4.443B |
| February 29, 2024 | 4.383B |
| February 28, 2024 | 4.479B |
| February 27, 2024 | 4.449B |
| February 26, 2024 | 4.395B |
| February 23, 2024 | 4.410B |
| February 22, 2024 | 4.480B |
| February 21, 2024 | 4.398B |
| February 20, 2024 | 4.304B |
| February 16, 2024 | 4.351B |
| February 15, 2024 | 4.327B |
| February 14, 2024 | 4.295B |
| February 13, 2024 | 4.318B |
| February 12, 2024 | 4.474B |
| February 09, 2024 | 4.445B |
| February 08, 2024 | 4.644B |
| February 07, 2024 | 4.593B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
2.777B
Minimum
Jan 27 2022
7.278B
Maximum
Aug 16 2019
4.871B
Average
4.759B
Median
Enterprise Value Benchmarks
| Stryker Corp | 134.46B |
| Boston Scientific Corp | 107.39B |
| ResMed Inc | 27.14B |
| Abbott Laboratories | 190.29B |
| Insulet Corp | 12.23B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 31.24M |
| Revenue (Quarterly) | 336.25M |
| Total Expenses (Quarterly) | 290.27M |
| EPS Diluted (Quarterly) | 0.61 |
| Gross Profit Margin (Quarterly) | 52.90% |
| Profit Margin (Quarterly) | 9.29% |
| Earnings Yield | 3.03% |
| Operating Earnings Yield | 4.32% |
| Normalized Earnings Yield | 3.208 |